Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 5 spellings of its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list Vivus with 3 drug applications, 2 510(k) clearances, 1 drug recall and 1 OPDP letter. The most recent is a drug recall dated Jun 23, 2023: PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, ….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Jun 23, 2023 | PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: Class III · Failed Stability Specifications | Drug recalls |
| May 22, 2019 | Untitled letter: QSYMIAOffice of Prescription Drug Promotion | OPDP letters |
| Dec 19, 2000 | ACTIS ADJUSTABLE CONSTRICTION LOOPK003115 · LKY | 510(k) clearances |
| Dec 10, 1996 | ACTIS (VENOUS FLOW CONTROLLER)K962915 · LKY | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
